NEW YORK (360Dx) – Nightingale Health said on Monday that it will analyze biomarker profiles in the blood samples of 150,000 participants in a Mexico City Prospective Study being conducted to track diseases in a Hispanic population.

Nightingale said that as part of the study, it will perform large-scale metabolic profiling under a contract with the Nuffield Department of Population Health at the University of Oxford in the UK.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.